UnitedHealth Group faces short-term challenges, but strong fundamentals, undervaluation, and long-term growth potential make ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...

UnitedHealth's dip offers long-term value, backed by strong fundamentals, rising dividends, and growth potential. Learn why ...

UnitedHealth Group prepared talking points for its shareholder meeting this week. The company published them Wednesday after ...

UnitedHealth Group has had a difficult year marked by a dramatic stock drop, leadership shake-up and mounting regulatory ...

UnitedHealth said that Hemsley intends to stay on as CEO for at least three years. Its governance committee reviews and ...

UnitedHealthcare and Optum's struggles with an evolving Medicare Advantage market have investors questioning if valued-based ...

Will Eubanks: At EA, we believe in the best of both worlds: leveraging AI and automation to boost efficiency while staying ...

Despite rumblings of dissatisfaction, UnitedHealth shareholders voted to support a $60 million stock package for CEO Stephen Hemsley.

UnitedHealth Group shareholders signed off on the planned compensation package for newly-reinstated CEO Stephen Hemsley. Hemsley, who returned to the CEO role last month, will earn a $1 million ...

With a price target of $377, analysts from the Bernstein SocGen Group reiterated their Outperform rating on UnitedHealth Group Incorporated (NYSE:UNH) on June 4. The analysts outlined the company’s ...

Retail sentiment around UnitedHealth Group turned cautious after the company reportedly prepared a confidential internal memo ...